World's Best Scientists 2026 revealed!
Mary K. Gospodarowicz

Mary K. Gospodarowicz

D-Index & Metrics

Medicine

D-Index
102
Citations
63018
World Ranking
7497
National Ranking
288

Mary K. Gospodarowicz publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Mary K. Gospodarowicz sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 562 publications — 67th percentile

67% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Mary K. Gospodarowicz D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Mary K. Gospodarowicz sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 102 D-Index — 63rd percentile

63% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Mary K. Gospodarowicz is affiliated with the Princess Margaret Cancer Centre in Canada. The main field of study focuses on Medicine, with a particular emphasis on Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine, Oncology, Public Health, Environmental and Occupational Health, and Economics and Econometrics.

The scientist's research covers several core topics, including:

  • Advances in Oncology and Radiotherapy
  • Prostate Cancer Treatment and Research
  • Global Cancer Incidence and Screening
  • Global Health and Surgery
  • Prostate Cancer Diagnosis and Treatment
  • Advanced Radiotherapy Techniques
  • Economic and Financial Impacts of Cancer

Recent publications highlight a range of issues spanning global health, cancer treatment, and radiotherapy, such as:

  • "Priorities for cancer research in low- and middle-income countries: a global perspective," 2022, Nature Medicine
  • "Clinical integration of machine learning for curative-intent radiation treatment of patients with prostate cancer," 2021, Nature Medicine
  • "Global Radiotherapy: Current Status and Future Directions-White Paper," 2021, JCO Global Oncology
  • "Radiotherapy and theranostics: a Lancet Oncology Commission," 2024, The Lancet Oncology
  • "Curative-intent Metastasis-directed Therapies for Molecularly-defined Oligorecurrent Prostate Cancer: A Prospective Phase II Trial Testing the Oligometastasis Hypothesis," 2021, European Urology

Frequent publication venues include:

  • The Lancet Oncology
  • Journal of Clinical Oncology
  • International Journal of Radiation Oncology*Biology*Physics
  • Nature Medicine
  • JCO Global Oncology

Among frequent collaborators are:

  • Peter Chung
  • Charles Catton
  • Alejandro Berlín
  • Andrew Bayley
  • Padraig Warde

Best Publications

  • TNM classification of malignant tumours

    L. H. Sobin;M. K. Gospodarowicz;Ch. Wittekind

  • Alleviating the access abyss in palliative care and pain relief—an imperative of universal health coverage: the Lancet Commission report

    Felicia Marie Knaul;Paul E Farmer;Eric L Krakauer;Eric L Krakauer;Liliana De Lima

  • Expanding global access to radiotherapy

    Rifat Atun;David A Jaffray;David A Jaffray;David A Jaffray;Michael B Barton;Freddie Bray

  • Comprar TNM Classification of Malignant Tumours, 7th Edition | C. Wittekind | 9781444332414 | Wiley

    C. Wittekind;Mary K. Gospodarowicz;Leslie H. Sobin

  • Expansion of cancer care and control in countries of low and middle income: a call to action.

    Paul Farmer;Julio Frenk;Felicia M Knaul;Lawrence N Shulman

  • Second Cancers Among 40 576 Testicular Cancer Patients: Focus on Long-term Survivors

    Lois B. Travis;Sophie D. Fosså;Sara J. Schonfeld;Mary L. McMaster

  • Report of an International Workshop to Standardize Baseline Evaluation and Response Criteria for Primary CNS Lymphoma

    Lauren E. Abrey;Tracy T. Batchelor;Andrés J.M. Ferreri;Mary Gospodarowicz

  • Breast Cancer Following Radiotherapy and Chemotherapy Among Young Women With Hodgkin Disease

    Lois B. Travis;Deirdre A. Hill;Graça M. Dores;Mary Gospodarowicz

  • Report on a workshop convened to discuss the pathological and staging classifications of gastrointestinal tract lymphoma

    A Rohatiner;F d'Amore;B Coiffier;D Crowther

  • Prognostic Factors for Relapse in Stage I Seminoma Managed by Surveillance: A Pooled Analysis

    Padraig Warde;Lena Specht;Alan Horwich;Tim Oliver

  • Combined androgen deprivation therapy and radiation therapy for locally advanced prostate cancer: a randomised, phase 3 trial

    Padraig Warde;Malcolm David Mason;Keyue Ding;Peter Kirkbride

  • Second Malignant Neoplasms Among Long-Term Survivors of Hodgkin’s Disease: A Population-Based Evaluation Over 25 Years

    Graça M. Dores;Catherine Metayer;Rochelle E. Curtis;Charles F. Lynch

  • Lung Cancer Following Chemotherapy and Radiotherapy for Hodgkin's Disease

    Lois B. Travis;Mary Gospodarowicz;Rochelle E. Curtis;E. Aileen Clarke

  • Nongastric marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue.

    Emanuele Zucca;Annarita Conconi;Ennio Pedrinis;Sergio Cortelazzo

  • Risk of Second Malignant Neoplasms Among Long-term Survivors of Testicular Cancer

    Lois B. Travis;Rochelle E. Curtis;Joseph F. Fraumeni;John D. Boice

  • Intermittent Androgen Suppression for Rising PSA Level after Radiotherapy

    J. M Crook;C. J O'Callaghan;G Duncan;D. P Dearnaley

  • Patterns of Outcome and Prognostic Factors in Primary Large-Cell Lymphoma of the Testis in a Survey by the International Extranodal Lymphoma Study Group

    E. Zucca;A. Conconi;T.I. Mughal;A.H. Sarris

  • The TNM classification of prostate cancer

    F H Schröder;P Hermanek;L Denis;W R Fair

  • Improved local control of invasive bladder cancer by concurrent cisplatin and preoperative or definitive radiation. The National Cancer Institute of Canada Clinical Trials Group.

    C. M. L. Coppin;M. K. Gospodarowicz;K. James;I. F. Tannock

  • Treatment of metastatic prostatic cancer with low-dose prednisone: evaluation of pain and quality of life as pragmatic indices of response.

    I Tannock;M Gospodarowicz;W Meakin;T Panzarella

Frequent Co-Authors

Padraig Warde
Padraig Warde Princess Margaret Cancer Centre
Charles Catton
Charles Catton University of Toronto
David A. Jaffray
David A. Jaffray The University of Texas MD Anderson Cancer Center
Michael Milosevic
Michael Milosevic Princess Margaret Cancer Centre
Robert G. Bristow
Robert G. Bristow University of Manchester
Melania Pintilie
Melania Pintilie Princess Margaret Cancer Centre
Brian O'Sullivan
Brian O'Sullivan Princess Margaret Cancer Centre
Michael A.S. Jewett
Michael A.S. Jewett University of Toronto
Leslie H. Sobin
Leslie H. Sobin National Cancer Institute
Felicia Marie Knaul
Felicia Marie Knaul University of Miami

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Medicine in the USA opens the door to numerous related careers beyond becoming a physician. Many students interested in healthcare explore alternative pathways to meet the increasing demand for professionals in administration and advanced nursing practice.

For those drawn to leadership and organizational roles, pursuing a health administration degree can lead to rewarding opportunities in hospital management, public health, and healthcare consulting. Students looking for an advanced credential may consider an affordable mha online to enhance their administrative expertise and career prospects without the burden of excessive debt.

Nursing professionals seeking to move into leadership or specialized clinical roles can benefit from the cheapest bsn to dnp programs, offering a more accessible pathway to a Doctor of Nursing Practice degree. Similarly, students interested in medication management and pharmacy practice can advance their careers through online pharmacist programs, which provide flexible options for earning a PharmD.

Exploring these affordable and flexible online programs allows prospective students to align their education with long-term career goals in the diverse field of healthcare.

Best Scientists Citing Mary K. Gospodarowicz

Trending Scientists

Recently Published Articles